101409-58-9 Usage
Uses
Used in Pharmaceutical Industry:
(10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol is used as a pharmaceutical compound for its potential biological and pharmacological activities. Its unique structure and functional groups may contribute to the development of new drugs and therapies.
Used in Medicinal Research:
In the field of medicinal research, (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol serves as a subject for investigation. Scientists are exploring its potential applications in treating various diseases and conditions, as well as understanding its interactions with biological systems.
Used in Drug Development:
(10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol is utilized in drug development to create novel therapeutic agents. Its unique chemical structure may offer new avenues for the treatment of diseases and the enhancement of existing medications.
Note: The specific applications and industries for (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol are not explicitly mentioned in the provided materials. The uses listed above are inferred based on the compound's potential biological and pharmacological activities and its classification as a sesquiterpene natural product. Further research and development are required to determine the exact applications and industries where (10S)-12-Methoxy-9,10-seco-9,20-cycloabieta-8,11,13-triene-10,11-diol can be effectively utilized.
Check Digit Verification of cas no
The CAS Registry Mumber 101409-58-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,4,0 and 9 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 101409-58:
(8*1)+(7*0)+(6*1)+(5*4)+(4*0)+(3*9)+(2*5)+(1*8)=79
79 % 10 = 9
So 101409-58-9 is a valid CAS Registry Number.
101409-58-9Relevant academic research and scientific papers
Thommen, Christophe,Neuburger, Markus,Gademann, Karl
, p. 120 - 127 (2017)
A divergent synthesis of 10 icetexane natural products based on a proposed biogenetic cationic ring expansion of a reduced carnosic acid derivative is described. Of these icetexanes, (+)-salvicanol, (?)-cyclocoulterone, (?)-coulterone, (?)-obtusinone D, and (?)-obtusinone E have been synthesized for the first time. In addition, the hypothesis for the non-enzymatic biogenesis of benzo[1,3]dioxole natural products has been experimentally investigated. Additional experimental evidence for the abiotic formation of the methylenedioxy unit is provided, as photolysis of the quinone (+)-komaroviquinone resulted in the formation of the [1,3]dioxole-containing natural product (?)-cyclocoulterone and (+)-komarovispirone.
